Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: This study sought to determine the impact of surgical versus transcatheter aortic valve replacement in patients with low-flow, low-gradient aortic stenosis.
Methods: This was an observational study of consecutive aortic valve replacements for severe aortic stenosis from 2010 to 2023. Patients with low-flow, low-gradient aortic stenosis (aortic valve mean gradient <40 mm Hg and a stroke volume index <35 mL/m) were included. Both classical (ejection fraction <50%) and paradoxical (ejection fraction ≥50%) subtypes were included. Concomitant procedures and history of aortic valve replacement were excluded. Patients were dichotomized by intervention.
Results: A total of 575 patients underwent isolated, first-time aortic valve replacement for low-flow, low-gradient aortic stenosis, of whom 248 (43%) were low operative risk (Society of Thoracic Surgeons Predicted Risk of Mortality <4%). A total of 131 patients (52.8%) underwent surgical aortic valve replacement, and 117 patients (47.2%) underwent transcatheter aortic valve replacement. Those undergoing transcatheter aortic valve replacement were older than those undergoing surgical aortic valve replacement: 79.0 [76.0-84.0] years versus 66.0 [59.0-73.0] years (P < .001). The incidence of 30-day mortality, stroke, and pacemaker was not different across each group, but the incidence of paravalvular leak was higher in the transcatheter aortic valve replacement group. At 1-year follow-up, aortic valve mean gradient (9.0 [7.0-12.0] mm Hg) and ejection fraction (55.0% [40.0-60.0]) were no different across each group. On multivariable analysis, transcatheter aortic valve replacement was not associated with an increased hazard of death compared with surgical aortic valve replacement (hazard ratio, 1.38, 95% CI, 0.72-2.66, P = .34) or an increased hazard of heart failure readmission (hazard ratio, 1.70, 95% CI, 0.88-3.30, P = .11) compared with surgical aortic valve replacement.
Conclusions: For patients with low-flow, low-gradient aortic stenosis, surgical and transcatheter approaches to aortic valve replacement may be equally as advantageous with respect to long-term outcomes.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12283094 | PMC |
| http://dx.doi.org/10.1016/j.jtcvs.2025.04.034 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Preoperative Echocardiography in Pectus Excavatum: High Rate of Incidental Findings, Low but Clinically Important Yield of Significant Anomalies.
J Pediatr Surg
September 2025
University of Utah, Department of Surgery, Division of Pediatric Surgery. Electronic address:
Background: Routine preoperative echocardiograms (ECHOs) are frequently obtained in patients undergoing minimally invasive repair of pectus excavatum (MIRPE), but the benefit and necessity of preoperative screening remain debated. In this study, we sought to quantify the proportion of preoperative ECHOs that had clinically significant findings.
Methods: We conducted a retrospective review of 255 patients who underwent MIRPE at a single pediatric referral center from 2018 to 2023.
Oral anticoagulation in patients with atrial fibrillation and heart valve prosthesis: a substudy from the LAAOS III Trial.
J Thorac Cardiovasc Surg
September 2025
Population Health Research Institute, Hamilton Health Sciences, McMaster University, Ontario, Canada.
Objective: Societal guidelines recommend vitamin K antagonists (VKAs) for atrial fibrillation patients with recent biological valve implantation, but the safety and efficacy of direct oral anticoagulants (DOACs) in this setting remain uncertain, especially in the early postoperative period. This substudy of the Left Atrial Appendage Occlusion Study (LAAOS) III trial aimed to compare thromboembolic and bleeding outcomes in patients discharged on VKAs versus DOACs after bioprosthesis implantation or mitral valve repair.
Methods: A total of 2,645 patients were included, with 461 discharged on DOACs and 2184 on VKAs.
Clinical outcomes following TAVR for patients with low and very low gradient aortic stenosis.
Prog Cardiovasc Dis
September 2025
Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA. Electronic address:
Objectives: This study explores the impact of lower baseline aortic valve (AV) mean gradients on the clinical outcomes of patients with low-gradient aortic stenosis (LG AS) post-transcatheter aortic valve replacement (TAVR). Additionally, the study aims to understand the predictors of a lower baseline AV mean gradient (MG).
Background: Reduced left ventricular ejection fraction (LVEF) and low-flow states are known to correlate with worse clinical outcomes.
Automated detection of pediatric congenital heart disease from phonocardiograms using deep and handcrafted feature fusion.
Comput Biol Med
September 2025
Electrical and Computer System Engineering, Monash University, Clayton, Melbourne, 3800, VIC, Australia.
Congenital heart disease (CHD) is the most common type of birth defect, impacting about 1% of live births worldwide. Echocardiography, the gold-standard diagnostic method, is costly and inaccessible in low-resource settings. Diagnosis is delayed due to limited skilled experts, whose ability to interpret pathological patterns varies significantly, causing inter- and intra-clinician variability.
View Article and Find Full Text PDFClinical and Laboratory Predictors for the Development of Heart Valve Diseases in Chronic Kidney Disease: A Systematic Review.
Arq Bras Cardiol
September 2025
Escola Bahiana de Medicina e Saúde Pública, Salvador, BA - Brasil.
Background: Chronic kidney disease (CKD) is associated with a higher prevalence of valvular diseases and increased mortality from cardiovascular causes. Factors that influence the genesis of cardiac valve calcification (CVC) in these patients are not well-defined.
Objective: To determine the risk factors for valvular calcification in patients with CKD.